Literature DB >> 1371722

Discordant results in human chorionic gonadotropin assays.

L A Cole1, A Kardana.   

Abstract

Discordance has been reported in human chorionic gonadotropin (hCG) concentrations measured by different immunoassay kits. We examined the results for 40 serum samples assayed with 10 different hCG immunoassay kits. Results varied considerably. Individual sample results varied by as much as 58-fold. Average results for different kits varied by as much as 1.4-fold for pregnancy (20 samples) and 2.2-fold for trophoblast disease (20 samples) serum. We investigated the causes of this discordance. hCG or hCG beta are general names for mixtures of hCG, hCG alpha, or hCG beta immunoreactive molecules in serum. These mixtures include regular hCG, nicked hCG (missing peptide linkages at beta 44-45 or beta 47-48), carbohydrate variants of hCG, hCG missing the beta-subunit C-terminal segment, free beta-subunit, beta-core fragment, and free alpha-subunit. We prepared standards for each of these major variants and measured their reactivities in the 10 hCG immunoassay kits. Free beta-subunit reactivity varied from nonrecognition (anti-beta:anti-alpha type kits; Hybritech Tandem-R and others) to overrecognition (one kit had five-fold greater affinity for free beta than for hCG). Kits with antibodies to beta-subunit C-terminal segment (Organon NML and others) failed to recognize hCG missing this segment, a component of serum hCG in trophoblast disease. Kits with anti-hCG antibodies (Serono MAIA-clone and others) had minimal recognition of nicked hCG (12%), a component of all serum hCG samples, and consistently gave the lowest values with all serum samples. We conclude that differences in recognition of nicked hCG, free beta, and these other hCG variants cause discordance in hCG immunoassay results.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371722

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Virilization associated with choriocarcinoma.

Authors:  R Rajatanavin; S Chuahirun; L Chailurkit; S Srisupundit; S Tungtrakul
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

2.  The significance of plasma progesterone levels during early pregnancies achieved after in vitro fertilization (IVF) treatment.

Authors:  A Shulman; Y Ghetler; E Weiss; Z Klein; Y Beyth; I Ben-Nun
Journal:  J Assist Reprod Genet       Date:  1994-03       Impact factor: 3.412

Review 3.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

4.  Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.

Authors:  James E Haddow; Monica R McClain; Geralyn Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter Bernstein; Mary E D'Alton
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

5.  False-positive beta-human chorionic gonadotropin values in the follow-up of gestational trophoblastic disease.

Authors:  V M Díaz Muñoz de la Espada; J A Arranz Arija; P Khosravi Shahi; S Encinas García; R Alvarez Alvarez; R González Beca
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

6.  Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.

Authors:  J Mora; N Gascón; J M Tabernero; J Rodríguez-Espinosa; F González-Sastre
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

7.  Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma.

Authors:  Hao Chen; Liru Tian; Jiahong Chen; Peng Sun; Runkun Han; Xingping Wu; Shuqin Dai
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.